(Q50558265)
Statements
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease (English)
John Boletis
Fatih Besisik
Maria Lúcia Ferraz
Laurent Alric
Diethelm Messinger
Andreas Tietz